Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy
Author:
Puig-Saus CristinaORCID, Sennino Barbara, Peng Songming, Wang Clifford L., Pan Zheng, Yuen Benjamin, Purandare Bhamini, An Duo, Quach Boi B., Nguyen Diana, Xia HuimingORCID, Jilani Sameeha, Shao Kevin, McHugh Claire, Greer John, Peabody Phillip, Nayak Saparya, Hoover JonathanORCID, Said Sara, Jacoby Kyle, Dalmas Olivier, Foy Susan P., Conroy Andrew, Yi Michael C., Shieh Christine, Lu William, Heeringa Katharine, Ma Yan, Chizari ShahabORCID, Pilling Melissa J., Ting Marc, Tunuguntla Ramya, Sandoval Salemiz, Moot Robert, Hunter Theresa, Zhao Sidi, Saco Justin D., Perez-Garcilazo Ivan, Medina Egmidio, Vega-Crespo Agustin, Baselga-Carretero Ignacio, Abril-Rodriguez Gabriel, Cherry Grace, Wong Deborah J., Hundal Jasreet, Chmielowski BartoszORCID, Speiser Daniel E., Bethune Michael T., Bao Xiaoyan R., Gros AlenaORCID, Griffith Obi L.ORCID, Griffith MalachiORCID, Heath James R.ORCID, Franzusoff Alex, Mandl Stefanie J., Ribas AntoniORCID
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference54 articles.
1. Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015). 2. Tran, E., Robbins, P. F. & Rosenberg, S. A. Final common pathway’ of human cancer immunotherapy: targeting random somatic mutations. Nat. Immunol. 18, 255–262 (2017). 3. Gros, A. et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat. Med. 22, 433–438 (2016). 4. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577–581 (2014). 5. Linnemann, C. et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat. Med. 21, 81–85 (2015).
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|